Researchers report that weight-loss surgery improves outcomes for patients with obesity and chronic kidney disease by significantly reducing the risk of kidney failure, major cardiovascular events and death…. read more.
A new meta-analysis of relevant clinical studies suggests that GLP 1 weight-loss drugs provide protection against heart attacks, strokes and premature death for up to 2.7 years. The… read more.
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.
Asundexian, an investigational anti clotting medication, appears to lower the risk of stroke without increasing bleeding in patients who have had a recent stroke or transient ischemic attack… read more.
The antidepressant duloxetine does not appear to prevent chemotherapy-associated nerve damage in colorectal cancer. This finding appeared in the JCO Oncology Advances on March 25, 2026 followed by… read more.
There appears to be no association between hormonal contraception and the prevalence of idiopathic intracranial hypertension, researchers reported on March 25, 2026 in Neurology, the medical journal of… read more.
Researchers report that the antidepressant fluvoxamine has significantly reduced long COVID–related fatigue, and that the diabetes drug metformin has no such benefit. “Patients taking fluvoxamine reported steadily improving… read more.
Researchers report that people with type 1 diabetes are nearly three times as likely to develop dementia compared to those without type 1 diabetes. The findings appeared in… read more.
GLP-1 medications, which are used to treat diabetes and obesity, appear to be associated with reduced hospital care and sickness absence from work for psychiatric reasons, researchers reported… read more.
In terms of clinically relevant bleeding, apixaban is safer than rivaroxaban in the treatment of venous thrombosis, researchers concluded on March 11, 2026 in the NEJM/New England Journal of… read more.
Canadian researchers report that new stimulant prescriptions to treat ADHD among adults have more than doubled since the start of the COVID-19 pandemic. And this finding was especially… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
